Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ComBaCaL aHT TwiC 1 & 2
NCT05684055Active, not recruiting
- Sponsor
- University Hospital Basel
- Start
- Sep 2023
- Primary completion
- May 2025
- Countries
- 2
01
Overview
Randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by University Hospital Basel. Primary endpoint: Blood pressure within target (<140/90 mmHg) at 12 months. Started Sep 2023; status: active, not recruiting.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05684055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05684055.